Last reviewed · How we verify
NCT06870695
Safety and Efficiency of Electrocautery De-Epithelization in Mammoplasty
trial testing Electrocautery in Safety in 100 participants. Completed in 25 February 2025.
25 February 2025
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 July 2024 |
| Primary completion | 25 February 2025 |
| Estimated completion | 25 February 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Electrocautery
- Surgical blade by scalpel
Conditions studied
- Safety — all drugs for Safety →
- Efficiency — all drugs for Efficiency →
- Electrocautery — all drugs for Electrocautery →
- De-Epithelization — all drugs for De-Epithelization →
Sponsor
Tanta University
Who can join
18 and older, female only, with Safety or Efficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate safety and efficiency of electrocautery de-epithelization in mammoplasty.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06870695
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electrocautery
Trials testing the same drug.
- NCT07050329 — Comparison of Operation Time, Drain Duration, and Seroma Formation After Modified Radical Mastectomy Using Ultrasonic Di · NA · completed
- NCT03014817 — Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial · NA · completed
- NCT02833558 — Purastat® vs Standard Therapy for Haemostasis During Endoscopic Submucosal Dissection · NA · completed
Other recruiting trials for Safety
Currently open trials in the same condition.
- NCT06818994 — Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced · Phase 1 · recruiting
- NCT07286656 — A Study of GensSci098 in Subjects With Graves' Disease · Phase 1 · recruiting
- NCT06760208 — A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market · recruiting
- NCT07157215 — An International Survey on the Use of NIV Outside the ICU · recruiting
- NCT06976229 — Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase · Phase 1 · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06870695 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 24 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06870695.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing